The glucose-lowering potential of exendin-4 orally delivered via a pH-sensitive nanoparticle vehicle and effects on subsequent insulin secretion in vivo
書誌事項
- 公開日
- 2011-04
- 権利情報
-
- https://www.elsevier.com/tdm/userlicense/1.0/
- https://www.elsevier.com/legal/tdmrep-license
- https://doi.org/10.15223/policy-017
- https://doi.org/10.15223/policy-037
- https://doi.org/10.15223/policy-012
- https://doi.org/10.15223/policy-029
- https://doi.org/10.15223/policy-004
- DOI
-
- 10.1016/j.biomaterials.2010.12.044
- 公開者
- Elsevier BV
この論文をさがす
収録刊行物
-
- Biomaterials
-
Biomaterials 32 (10), 2673-2682, 2011-04
Elsevier BV